Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitability.

MLA

Roth, Jonathan R., et al. “Development of Small-Molecule Tau-SH3 Interaction Inhibitors That Prevent Amyloid-β Toxicity and Network Hyperexcitability.” Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics, vol. 21, no. 1, Jan. 2024, p. e00291. EBSCOhost, https://doi.org/10.1016/j.neurot.2023.10.001.

APA

Roth, J. R., Rush, T., Thompson, S. J., Aldaher, A. R., Dunn, T. B., Mesina, J. S., Cochran, J. N., Boyle, N. R., Dean, H. B., Yang, Z., Pathak, V., Ruiz, P., Wu, M., Day, J. J., Bostwick, J. R., Suto, M. J., Augelli-Szafran, C. E., & Roberson, E. D. (2024). Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitability. Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics, 21(1), e00291. https://doi.org/10.1016/j.neurot.2023.10.001

Chicago

Roth, Jonathan R, Travis Rush, Samantha J Thompson, Adam R Aldaher, Trae B Dunn, Jacob S Mesina, J Nicholas Cochran, et al. 2024. “Development of Small-Molecule Tau-SH3 Interaction Inhibitors That Prevent Amyloid-β Toxicity and Network Hyperexcitability.” Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics 21 (1): e00291. doi:10.1016/j.neurot.2023.10.001.